Epirubicin approved for breast cancer treatment

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1999年 / 56卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2177 / 2177
页数：1
相关论文
共 50 条
  • [21] Triple negative breast cancer: approved treatment options and their mechanisms of action
    Aditya Mandapati
    Kiven Erique Lukong
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3701 - 3719
  • [22] SEQUENTIAL ALTERNATING MEDROXYPROGESTERONE ACETATE AND EPIRUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER
    SMITH, JA
    GREEN, MD
    RUSSELL, IS
    COLLINS, JP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1989, 59 (11): : 869 - 872
  • [23] A PILOT-STUDY OF QUINIDINE AND EPIRUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER
    JONES, RD
    KERR, DJ
    HARNETT, AN
    RANKIN, EM
    RAY, S
    KAYE, SB
    BRITISH JOURNAL OF CANCER, 1990, 62 (01) : 133 - 135
  • [24] A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer
    E. Esteban
    González de Sande
    J. Puertas
    J. Fra
    I. Palacio
    J.M. Vieitez
    J.L. Fernández
    I. Muñiz
    A. Modollel
    J. Carrasco
    M. Sala
    A.J. Lacave
    Breast Cancer Research and Treatment, 2000, 62 : 127 - 133
  • [25] Triple negative breast cancer: approved treatment options and their mechanisms of action
    Mandapati, Aditya
    Lukong, Kiven Erique
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3701 - 3719
  • [26] POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
    Velasco-Ruiz, Alejandro
    Nunez-Torres, Rocio
    Pita, Guillermo
    Wildiers, Hans
    Lambrechts, Diether
    Hatse, Sigrid
    Delombaerde, Danielle
    Van Brussel, Thomas
    Alonso, M. Rosario
    Alvarez, Nuria
    Herraez, Belen
    Vulsteke, Christof
    Zamora, Pilar
    Lopez-Fernandez, Teresa
    Gonzalez-Neira, Anna
    PHARMACEUTICS, 2021, 13 (11)
  • [27] Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
    Bhatia, Neha
    Thareja, Suresh
    MEDICAL ONCOLOGY, 2023, 40 (06)
  • [28] Feasibility study of dose dense epirubicin and cyclophosphamide in the primaly breast cancer treatment
    Morita, Sachi
    Inaishi, Takahiro
    Ota, Akiko
    Matsuoka, Ayumu
    Mizutani, Takehumi
    Shimokata, Tomoya
    Maeda, Osamu
    Mitsuma, Ayako
    Tsunoda, Nobuyuki
    Kikumori, Toyone
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
    Neha Bhatia
    Suresh Thareja
    Medical Oncology, 40
  • [30] Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
    David Jamieson
    Jo Lee
    Nicola Cresti
    Rosanna Jackson
    Melanie Griffin
    Julieanne Sludden
    Mark Verrill
    Alan V. Boddy
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 667 - 674
12345